Trial ID 20422 | Maryland Oncology Hematology Trial ID 20422 – Maryland Oncology Hematology

Trial ID 20422

Trial Information - Phase N/A

KRAS DetECT: KRAS mutation Detection to Evaluate Eligibility for Clinical Trials

Disease Specifics: (NSCLC)

Protocol ID: MA-MRTX-100

Sponsor: Mirati Therapeutics Inc.

Status: OPEN TO ENROLLMENT

Contact us regarding Clinical Trials at MOHRSCH@usoncology.com
or call us at 877-664-7724

Disease Types

Lung

Investigator

Gaffar MD, Yousuf

Status

OPEN TO ENROLLMENT

Sponsor

Mirati Therapeutics Inc.

Quality Care Close to Home


View our locations on map!

Sign Up Today For Our E-Newsletter

  • This field is for validation purposes and should be left unchanged.
United in Healing with The US Oncology Network - Maryland Oncology Hematology